Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-(3-(2-(1-isopropyl-3-methyl-1h-1,2-4-triazol-5-yl)-5,6-dihydrobenzo(f)imidazo(1,2-d)(1,4)oxazepin-9-yl)-1h-pyrazol-1-yl)-2-methylpropanamide
2. Gdc-0032
3. Gdc0032
4. Ro5537381
1. Gdc-0032
2. 1282512-48-4
3. 2-(4-(2-(1-isopropyl-3-methyl-1h-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1h-pyrazol-1-yl)-2-methylpropanamide
4. Gdc 0032
5. Taselisib [inn]
6. Gdc0032
7. Taselisib (gdc0032)
8. Rg-7604
9. Rg7604
10. Chembl2387080
11. L08j2o299m
12. Rg 7604
13. 2-methyl-2-(4-{2-[3-methyl-1-(propan-2-yl)-1h-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-1h-pyrazol-1-yl)propanamide
14. Taselisib [usan:inn]
15. Unii-l08j2o299m
16. 2-(4-(2-(1-isopropyl-3-methyl-1h-1,2,4-triazol-5-yl)-5,6-dihydrobenzo(f)imidazo(1,2-d)(1,4)oxazepin-9-yl)-1h-pyrazol-1-yl)-2-methylpropanamide
17. Taselisibgdc-0032
18. Taselisib (usan/inn)
19. Taselisib [usan]
20. Taselisib [who-dd]
21. Taselisib (gdc-0032)
22. Gtpl7794
23. Schembl1485247
24. Dtxsid00155842
25. Hms3674g19
26. Amy39941
27. Bcp09253
28. Ex-a1581
29. Bdbm50434806
30. Mfcd26142641
31. Nsc777425
32. Nsc800985
33. S7103
34. Zinc68267049
35. Akos026750303
36. Ccg-269338
37. Cs-1817
38. Db12108
39. Gdc-0032, Taselisib; Rg-7604
40. Nsc-777425
41. Nsc-800985
42. Sb16576
43. Ncgc00387039-02
44. 2-methyl-2-[4-[2-(5-methyl-2-propan-2-yl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrazol-1-yl]propanamide
45. Ac-32794
46. As-10662
47. Bg166285
48. Hy-13898
49. D11774
50. J-690119
51. Q27088940
52. 1395408-87-3
53. 1h-pyrazole-1-acetamide, 4-(5,6-dihydro-2-(3-methyl-1-(1-methylethyl)-1h-1,2,4-triazol-5-yl)imidazo(1,2-d)(1,4)benzoxazepin-9-yl)-.alpha.,.alpha.-dimethyl-
54. 1h-pyrazole-1-acetamide, 4-[5,6-dihydro-2-[3-methyl-1-(1-methylethyl)-1h-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]-alpha,alpha-dimethyl-
55. 3-({[(3r,5r)-3-butyl-3-ethyl-7-methoxy-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}amino)pentanedioic Aci D
56. 4-[5,6-dihydro-2-[3-methyl-1-(1-methylethyl)-1h-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]-
57. A,
58. A-dimethyl-1h-pyrazole-1-acetamide
Molecular Weight | 460.5 g/mol |
---|---|
Molecular Formula | C24H28N8O2 |
XLogP3 | 1.8 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 5 |
Exact Mass | 460.23352217 g/mol |
Monoisotopic Mass | 460.23352217 g/mol |
Topological Polar Surface Area | 119 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 751 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?